Isoform specificity for oestrogen receptor and thyroid hormone receptor genes and their interactions on the NR2D gene promoter.
Oestrogens are critical for the display of lordosis behaviour and, in recent years, have also been shown to be involved in synaptic plasticity. In the brain, the regulation of ionotropic glutamate receptors has consequences for excitatory neurotransmission. Oestrogen regulation of the N-methyl-d-aspartate receptor subunit 2D (NR2D) has generated considerable interest as a possible molecular mechanism by which synaptic plasticity can be modulated. Since more than one isoform of the oestrogen receptor (ER) exists in mammals, it is possible that oestrogen regulation via the ERalpha and ERbeta isoforms on the NR2D oestrogen response element (ERE) is not equivalent. In the kidney fibroblast (CV1) cell line, we show that in response to 17beta-oestradiol, only ERalpha, not ERbeta, could upregulate transcription from the ERE which is in the 3' untranslated region of the NR2D gene. When this ERE is in the 5' position, neither ERalpha nor ERbeta showed transactivation capacity. Thyroid hormone receptor (TR) modulation of ER mediated induction has been shown for other ER target genes, such as the preproenkephalin and oxytocin receptor genes. Since the various TR isoforms exhibit distinct roles, we hypothesized that TR modulation of ER induction may also be isoform specific. This is indeed the case. The TRalpha1 isoform stimulated ERalpha mediated induction from the 3'-ERE whereas the TRbeta1 isoform inhibited this induction. This study shows that isoforms of both the ER and TR have different transactivation properties. Such flexible regulation and crosstalk by nuclear receptor isoforms leads to different transcriptional outcomes and the combinatorial logic may aid neuroendocrine integration.
Vasudevan
N
N
Laboratory of Neurobiology and Behavior, The Rockefeller University, New York, NY, USA. nuv1@psu.edu
Kia
H K
HK
Inoue
S
S
Muramatsu
M
M
Pfaff
D
D
D020413:3' Untranslated Regions / Q000502:physiology; D000818:Animals; D002460:Cell Line; D004958:Estradiol / Q000494:pharmacology; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D005347:Fibroblasts / Q000166:cytology; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D007668:Kidney / Q000166:cytology; D011401:Promoter Regions, Genetic / Q000502:physiology*; D051381:Rats; D020239:Receptor Cross-Talk / Q000502:physiology; D011960:Receptors, Estrogen / Q000235:genetics*; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics*; D011988:Receptors, Thyroid Hormone / Q000235:genetics*; D015533:Transcriptional Activation / Q000187:drug effects / Q000502:physiology; D014284:Triiodothyronine / Q000494:pharmacology
D020413:3' Untranslated Regions; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; C464436:NR2D NMDA receptor; D011960:Receptors, Estrogen; D016194:Receptors, N-Methyl-D-Aspartate; D011988:Receptors, Thyroid Hormone; D014284:Triiodothyronine; D004958:Estradiol